Review
Cardiovascular side effects of newer antidepressants
1Psychiatry Service, Hunter Holmes McGuire Veterans Affairs Medical Center Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia
2Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia Department of Internal Medicine, Cardiology Division, Mayo Clinic, Scottsdale, Arizona, USA
3Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia Department of Internal Medicine, Cardiology Division, Mayo Clinic, Scottsdale, Arizona, USA
2Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia Department of Internal Medicine, Cardiology Division, Mayo Clinic, Scottsdale, Arizona, USA
3Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia Department of Internal Medicine, Cardiology Division, Mayo Clinic, Scottsdale, Arizona, USA
Anatol J Cardiol 2007; 3(7): 305-309 PubMed ID: 17785222
Abstract
We review the cardiovascular effects of newer antidepressants. Although further studies are warranted, the safety of the selective serotonin reuptake inhibitors and the serotonin norepinephrine reuptake inhibitors on patients with comorbid cardiac conditions is impressive. Newer antidepressants should be considered as first-line agents for the treatment of depression in patients with and without cardiovascular disease.
Keywords: Antidepressant drugs, atrial fibrillation, blood pressure, bradycardia, cardiac death, cardiovascular effects, electrocardiogram, hypertension, hypotension, QT interval, ventricular premature beats, tachycardia
Yeni antidepresanların kardiyovasküler yan etkileri
1Psychiatry Service, Hunter Holmes McGuire Veterans Affairs Medical Center Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia
2Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia Department of Internal Medicine, Cardiology Division, Mayo Clinic, Scottsdale, Arizona, USA
3Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia Department of Internal Medicine, Cardiology Division, Mayo Clinic, Scottsdale, Arizona, USA
2Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia Department of Internal Medicine, Cardiology Division, Mayo Clinic, Scottsdale, Arizona, USA
3Department of Psychiatry Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia Department of Internal Medicine, Cardiology Division, Mayo Clinic, Scottsdale, Arizona, USA
The Anatolian Journal of Cardiology 2007; 3(7): 305-309 PMID: 17785222
Anahtar Kelimeler: Antidepresan ajanlar, atriyal fibrilasyon, kan basıncı, bradikardi, kardiyak ölüm, kardiyovasküler etkileri, elektrokardi- yogram, hipertansiyon, hipotansiyon, QT aralığı, ventriküler ektopik vurular, taflikardi